Eli Lilly to deploy Veeva Vault CRM globally

Eli Lilly & Co. said it will implement Veeva Systems Inc.'s Veeva Vault CRM globally to streamline commercial operations and enhance customer engagement across its international markets.

The move follows a strategic review of Eli Lilly's existing commercial systems and aims to consolidate disparate platforms into a single, cloud-based solution. The deployment will cover Eli Lilly's pharmaceutical, biotechnology and medical device businesses, with full rollout expected within the next two years.

Veeva Vault CRM, part of Veeva's broader cloud suite for life sciences, is designed to support regulatory compliance, data security and real-time analytics for commercial teams. The platform is widely adopted in the pharmaceutical industry, particularly among large-cap drugmakers seeking to modernize commercial infrastructure.

Eli Lilly did not disclose financial terms of the agreement or specify which regions would see the earliest implementation. A company spokesperson said the initiative aligns with Eli Lilly's broader digital transformation strategy to improve operational efficiency and patient access to therapies.

The decision reflects broader trends in the pharmaceutical sector, where companies are increasingly shifting from legacy on-premise systems to cloud-based commercial platforms to manage complex global supply chains and regulatory requirements.